SLS 18RS-478 ENGROSSED
2018 Regular Session
SENATE BILL NO. 110
BY SENATOR JOHNS
PHARMACEUTICALS. Provides relative to definitions used for the prescription
monitoring program. (8/1/18)
1 AN ACT
2 To amend and reenact R.S. 40:1003(10), relative to definitions used for implementation of
3 the prescription monitoring program; to provide for an update to certain terms; and
4 to provide for related matters.
5 Be it enacted by the Legislature of Louisiana:
6 Section 1. R.S. 40:1003(10) is hereby amended and reenacted to read as follows:
7 ยง1003. Definitions
8 * * *
9 (10) "Drugs of concern" means drugs other than controlled substances as
10 defined by rule which demonstrate a potential for abuse or whose use requires
11 tracking for public health purposes.
12 * * *
The original instrument and the following digest, which constitutes no part
of the legislative instrument, were prepared by Christine Arbo Peck.
DIGEST
SB 110 Engrossed 2018 Regular Session Johns
Present law defines drugs of concern as drugs other than controlled substances that
demonstrate a potential for abuse. Proposed law retains present law and adds drugs whose
Page 1 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 110
SLS 18RS-478 ENGROSSED
use requires tracking for public health purposes.
Effective August 1, 2018.
(Amends R.S. 40:1003(10))
Page 2 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.